| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |